Association Between Adiposity and Left Ventricular Mass in Children With Hypertension

Tammy M Brady1, Lawrence J Appel2, Kathryn W Holmes3

  • 1Division of Pediatric Nephrology, Johns Hopkins University School of Medicine, Baltimore, MD.

Insights

Obesity worsens left ventricular hypertrophy (LVH) in hypertensive children, increasing left ventricular mass index (LVMI) over time. Adiposity, not just blood pressure, is a key factor in pediatric hypertensive heart disease progression.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Disease Risk Factors
  • Hypertension Research

Background:

  • Left ventricular hypertrophy (LVH) is common in children with hypertension.
  • Blood pressure alone does not reliably predict LVH presence in this population.
  • Obesity is an emerging concern in pediatric hypertension and its cardiovascular sequelae.

Purpose of the Study:

  • To investigate the association between obesity-related risk factors and left ventricular mass index (LVMI) in hypertensive children.
  • To determine if adiposity's effect on LVMI is mediated by blood pressure-dependent or -independent pathways.
  • To examine the longitudinal changes in LVMI related to weight status over one year.

Main Methods:

  • A 1-year prospective cohort study involving 49 hypertensive children.
  • Assessment of baseline and follow-up measurements including LVMI, body mass index z-score, and blood pressure parameters.
  • Statistical analysis to identify associations between adiposity, blood pressure, and LVMI changes.

Main Results:

  • Over half (51%) of the children were overweight or obese at baseline.
  • Children who were overweight/obese showed a significantly greater increase in LVMI compared to normal-weight peers (6.4 vs. 0.95 g/m(2.7)).
  • Baseline body mass index z-score was an independent predictor of LVMI change (β=4.08, P=.002), with partial mediation by pulse pressure and aldosterone.

Conclusions:

  • Adiposity is strongly associated with LVH and increasing LVMI in hypertensive children.
  • Obesity represents a critical, modifiable risk factor driving cardiac changes in pediatric hypertension.
  • Hypertensive youth exhibit multiple, worsening cardiovascular risk factors, highlighting the need for comprehensive management strategies.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
708
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.4K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.0K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
715
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.3K